Quick Answer
Inspire Medical Systems, Inc. reported Stockholders Equity of $781.16 million for the year ending 2025.
- Inspire Medical Systems, Inc. showed an increase of +13.3% in Stockholders Equity from 2024 to 2025.
- This data is from Inspire Medical Systems, Inc.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: -$4.94 million | Q2 2018: $102.58 million | Q3 2018: $98.31 million | Q1 2019: $157.42 million | Q2 2019: $152.49 million | Q3 2019: $146.05 million | Q1 2020: $127.40 million | Q2 2020: $233.59 million | Q3 2020: $228.82 million | Q1 2021: $223.13 million | Q2 2021: $219.91 million | Q3 2021: $220.30 million | Q1 2022: $225.06 million | Q2 2022: $226.98 million | Q3 2022: $470.20 million | Q1 2023: $504.65 million | Q2 2023: $529.36 million | Q3 2023: $544.18 million | Q1 2024: $589.02 million | Q2 2024: $638.07 million | Q3 2024: $696.56 million | Q1 2025: $635.74 million | Q2 2025: $677.81 million | Q3 2025: $666.46 million.
- Over the full 11 years of available data (2015 to 2025), Inspire Medical Systems, Inc.'s Stockholders Equity has grown by 68,502.8%.
- Historical annual values: Fiscal year 2025: $781.16 million | Fiscal year 2024: $689.70 million | Fiscal year 2023: $572.51 million | Fiscal year 2022: $496.01 million | Fiscal year 2021: $229.05 million | Fiscal year 2020: $229.75 million | Fiscal year 2019: $139.84 million | Fiscal year 2018: $164.00 million | Fiscal year 2017: $1.33 million | Fiscal year 2016: -$6.61 million | Fiscal year 2015: -$1.14 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: